Notis McConarty Edward grew its position in Danaher Corporation (NYSE:DHR) by 2.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 26,075 shares of the conglomerate’s stock after buying an additional 730 shares during the quarter. Danaher Corporation accounts for approximately 1.4% of Notis McConarty Edward’s holdings, making the stock its 26th biggest holding. Notis McConarty Edward’s holdings in Danaher Corporation were worth $2,237,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in the company. Norway Savings Bank increased its position in shares of Danaher Corporation by 0.4% in the second quarter. Norway Savings Bank now owns 2,238 shares of the conglomerate’s stock valued at $189,000 after buying an additional 10 shares in the last quarter. National Asset Management Inc. boosted its stake in shares of Danaher Corporation by 0.4% during the second quarter. National Asset Management Inc. now owns 3,767 shares of the conglomerate’s stock valued at $318,000 after acquiring an additional 14 shares during the last quarter. First Financial Corp IN boosted its stake in shares of Danaher Corporation by 0.8% during the second quarter. First Financial Corp IN now owns 2,720 shares of the conglomerate’s stock valued at $230,000 after acquiring an additional 21 shares during the last quarter. Brighton Jones LLC boosted its stake in shares of Danaher Corporation by 0.4% during the second quarter. Brighton Jones LLC now owns 5,159 shares of the conglomerate’s stock valued at $435,000 after acquiring an additional 21 shares during the last quarter. Finally, Guardian Life Insurance Co. of America boosted its stake in shares of Danaher Corporation by 1.0% during the first quarter. Guardian Life Insurance Co. of America now owns 2,356 shares of the conglomerate’s stock valued at $202,000 after acquiring an additional 24 shares during the last quarter. Institutional investors and hedge funds own 75.38% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Danaher Corporation (DHR) Shares Bought by Notis McConarty Edward” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this report on another site, it was illegally stolen and republished in violation of United States & international trademark & copyright law. The legal version of this report can be read at https://www.thecerbatgem.com/2017/11/14/danaher-corporation-dhr-shares-bought-by-notis-mcconarty-edward.html.

A number of research firms recently commented on DHR. Zacks Investment Research lowered Danaher Corporation from a “buy” rating to a “hold” rating in a research note on Thursday, July 27th. BidaskClub lowered Danaher Corporation from a “hold” rating to a “sell” rating in a research note on Tuesday, July 25th. Citigroup Inc. set a $96.00 price objective on Danaher Corporation and gave the company a “buy” rating in a research note on Friday, July 21st. Cowen and Company reaffirmed a “buy” rating and set a $90.00 price objective on shares of Danaher Corporation in a research note on Wednesday, October 4th. Finally, J P Morgan Chase & Co reaffirmed an “overweight” rating and set a $95.00 price objective on shares of Danaher Corporation in a research note on Friday, September 8th. One analyst has rated the stock with a sell rating, four have issued a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $93.31.

In other news, insider William King sold 43,688 shares of Danaher Corporation stock in a transaction dated Thursday, August 31st. The stock was sold at an average price of $82.86, for a total value of $3,619,987.68. Following the transaction, the insider now directly owns 45,748 shares of the company’s stock, valued at approximately $3,790,679.28. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Donald J. Ehrlich sold 10,578 shares of Danaher Corporation stock in a transaction dated Tuesday, October 24th. The shares were sold at an average price of $90.82, for a total value of $960,693.96. Following the completion of the transaction, the director now directly owns 104,621 shares in the company, valued at $9,501,679.22. The disclosure for this sale can be found here. Insiders sold a total of 279,628 shares of company stock worth $25,304,394 over the last ninety days. Corporate insiders own 12.20% of the company’s stock.

Danaher Corporation (NYSE DHR) opened at $93.33 on Tuesday. The firm has a market capitalization of $64,162.62, a PE ratio of 23.71, a PEG ratio of 2.19 and a beta of 1.02. Danaher Corporation has a 52 week low of $76.27 and a 52 week high of $93.38. The company has a quick ratio of 1.00, a current ratio of 1.43 and a debt-to-equity ratio of 0.42.

Danaher Corporation (NYSE:DHR) last released its quarterly earnings data on Thursday, October 19th. The conglomerate reported $1.00 earnings per share for the quarter, beating the consensus estimate of $0.95 by $0.05. The business had revenue of $4.53 billion for the quarter, compared to analyst estimates of $4.47 billion. Danaher Corporation had a return on equity of 11.29% and a net margin of 13.36%. The company’s revenue was up 9.6% compared to the same quarter last year. During the same period in the previous year, the company posted $0.87 EPS. sell-side analysts anticipate that Danaher Corporation will post 3.99 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 27th. Stockholders of record on Friday, September 29th were paid a $0.14 dividend. This represents a $0.56 annualized dividend and a dividend yield of 0.60%. The ex-dividend date was Thursday, September 28th. Danaher Corporation’s dividend payout ratio is currently 16.52%.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Stock Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related stocks with our FREE daily email newsletter.